Leht 1 alates 20 tulemused
To compare the peri-implant clinical and radiographic status around bone-level narrow-diameter titanium-zirconium (TiZr) implants and titanium (Ti) implants placed in cigarette-smokers (CS) and never-smokers (NS).Partially edentulous CS and NS rehabilitated BACKGROUND
Prefabricated implant abutments made of zirconium dioxide (yttria-stabilized polycrystalline tetragonal zirconia; Y-TZP) have proved to be useful in the esthetically demanding anterior region and may also be useful for premolar and molar replacement because of their obvious positive
To assess the clinical performance of a prefabricated all-ceramic zirconium dioxide implant abutment for single-tooth replacement in the posterior region.Forty implants (Xive S plus screw type, Dentsply Sirona Implants) were inserted into the posterior OBJECTIVE
The aim of the present prospective clinical study was to evaluate and to compare the success and survival rates of narrow diameter implants made of titanium-zirconium alloy and commercially pure titanium.
METHODS
Forty-two healthy adult patients scheduled for implant-supported single
OBJECTIVE
In the present study, prefabricated abutments made of zirconium dioxide Y-TZP (tetragonal zirconia polycrystals) were inserted into the posterior region under controlled clinical conditions. The aim was to test whether abutments made of zirconium dioxide are suitable for this indication.
OBJECTIVE
Zirconia implant abutments have gained a much broader clinical use over the past few years. The aim of the present study was to assess the clinical performance of a pre-fabricated zirconium dioxide implant abutment for single-tooth replacement in the posterior region.
METHODS
Forty
Current use of zirconium oxide (ZrO₂)-based screw-retained restorations does not guarantee maximum contact of soft peri-implant tissues with ZrO₂, because veneering porcelain usually covers the major subgingival part of the restoration. Ceramics preclude direct interaction between zirconia and soft
OBJECTIVE
The aim of this study was to compare the clinical performance of metal-ceramic crowns made with an experimental alloy prepared by the Nordic Institute of Dental Materials, containing 15% zirconium and 85% titanium (Ti-15% Zr), and a high noble gold-palladium alloy
Analyze the 2-year clinical performance of single-unit titanium-zirconium (TiZr) alloy narrow-diameter (3.3 mm) dental implants with a hydrophilic surface (Straumann® Roxolid®, SLActive®) in patients with controlled type 2 diabetes mellitus (T2DM), measured using the glycated OBJECTIVE
To analyze marginal bone loss (MBL) and clinical parameters around narrow-diameter implants (NDIs - 3.3 mm) made of titanium/zirconium alloy (TiZr) in comparison with commercially pure titanium (cpTi) installed in the molar region of the mandible after 1 year in function.
METHODS
Ten
BACKGROUND
The aim of this study was to compare the 5-year survival and success rates of 3.3 mm dental implants either made from titanium-zirconium (TiZr) alloy or from Grade IV titanium (Ti Grade IV) in mandibular implant-based removable overdentures.
METHODS
The core study had a follow-up period
OBJECTIVE
The aim of this study was to compare crestal bone-level changes, soft tissue parameters and implant success and survival between small-diameter implants made of titanium/zirconium (TiZr) alloy or of Grade IV titanium (Ti) in edentulous mandibles restored with removable
OBJECTIVE
To assess the long-term clinical outcomes following non-surgical therapy of peri-implant diseases at two-piece zirconium implants.
METHODS
A total of 27 patients suffering from either (i) peri-implant mucositis (n = 24 implants), or (ii) peri-implantitis (n = 16 implants) completed a mean
We post-examined 112 apicectomies in 93 patients after an average placement period of 4.8 months (3-15.3 months) both clinically and radiologically in a prospective study to evaluate the security of success using zirconoxide ceramic pins. Clinical functioning was examined by means of the clinical
OBJECTIVE
To assess the efficacy of non-surgical therapy for the management of peri-implant diseases at a two-piece zirconium implant system.
METHODS
Thirty-four patients with 45 implants participated in this study. Seventeen patients (24 implants) were diagnosed with peri-implant mucositis and